"Serotonin Depression"—A Biochemical Subgroup Within the Affective Disorders?
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
The distribution of 5-hydroxyindoleacetic acid (5-HIAA) concentrations in the cerebrospinal fluid of 68 depressed patients was bimodal. Twenty-nine percent of the patients were in the lower mode, with a concentration of 5-HIAA below 15 nanograms per milliliter. Although there were no differences in overall severity of depression between the two modes, there was a significant correlation between the concentration of 5-HIAA and severity of depression in the lower, but not in the upper, mode. The finding suggests the existence of a biochemical subgroup of depressive disorder, characterized by a disturbance of serotonin turnover.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The serotonin pathway is by far the best described pathway in depression and several alterations in this pathway have been associated with suicidal behaviour.”
From Suicide and suicide risk (2019) · cites this paper as [129]
Citations
Cites
THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS: A REVIEW OF SUPPORTING EVIDENCE
SCHILDKRAUT, J. J. (1965) · American Journal of Psychiatry · doi:10.1176/ajp.122.5.509 · Cited by 3,492
5-Hydroxytryptamine in the Hind-Brain of Depressive Suicides
Shaw, D. M., Camps, F. E., & Eccleston, E. G. (1967) · British Journal of Psychiatry · doi:10.1192/bjp.113.505.1407 · Cited by 431
Abnormalities of Indoleamines in Affective Disorders
Coppen, A. (1972) · Archives of General Psychiatry · doi:10.1001/archpsyc.1972.01750230084016 · Cited by 304
Coppen, A. (1972) · Archives of General Psychiatry · doi:10.1001/archpsyc.1972.01750210042009 · Cited by 245
Åsberg, M., Bertilsson, L., Tuck, D., Cronholm, B., & Sjoqvist, F. (1973) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1973142277 · Cited by 242
Self-citationvan Praag, H. M., & Korf, J. (1971) · Psychopharmacologia · doi:10.1007/bf00402638 · Cited by 225
ACID MONOAMINE METABOLITES OF CEREBROSPINAL FLUID IN MENTAL DEPRESSION AND MANIA
Dencker, S. J., Malm, U., Roos, B. ‐., & Werdinius, B. (1966) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1966.tb04320.x · Cited by 218
CRONHOLM, B., & OTTOSSON, J. (1960) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1960.tb08351.x · Cited by 193
Homovanillic and 5-Hydroxyindoleacetic Acid in Cerebrospinal Fluid of Depressed Patients
Papeschi, R. (1971) · Archives of General Psychiatry · doi:10.1001/archpsyc.1971.01750160066012 · Cited by 179
Cerebral Monoamines and Depression: An Investigation With the Probenecid Technique
van Praag, H. M. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.01750360053007 · Cited by 174
Research works printed but not linked: 7
- Pare, C. M. B., Lancet 1969-II: 133 (1969).
- Lloyd, K. G., Adv. Biochem. Psychopharmacol 11: 387 (1974).
- Bourne, H. R., Lancet 1968-II: 805 (1968).
- Coppen, A., Lancet 1967-II: 1178 (1967).
- Ashcroft, G. W., Lancet 1966-II: 1049 (1966).
- Gurney, C., Proceedings of the 5th World Congress of Psychiatry: 330 (1971).
- Curzon, G., J. Psychiatr. Res. 9: 243 (1972).
Cited by
Items 201–300 of 678
Hersey, M., Samaranayake, S., Berger, S. N., Tavakoli, N. S., Mena, S., Nijhout, H. F., Reed, M. C., Best, J. A., Blakely, R., Reagan, L. P., et al. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.2618-20.2021 · Cited by 58
Saylor, R. A., Hersey, M., West, A., Buchanan, A. M., Berger, S. N., Nijhout, H. F., Reed, M. C., Best, J., & Hashemi, P. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00362 · Cited by 58
Paik, I.-H., Toh, K.-Y., Kim, J.-J., Lee, C., & Lee, C.-U. (2000) · Human Heredity · doi:10.1159/000022942 · Cited by 52
A double‐blind comparison of fluvoxamine and dothiepin in the treatment of major affective disorder
Mullin, J. M., Pandita‐Gunawardena, V. R., & Whitehead, A. M. (1988) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1988.tb08510.x · Cited by 54
Effect of S-adenosyl-L-methionine on serotonin metabolism in rat brain
Curcio, M., Catto, E., Stramentinoli, G., & Algeri, S. (1978) · Progress in Neuro-Psychopharmacology · doi:10.1016/0364-7722(78)90023-1 · Cited by 54
Approaches to Brain Amines in Psychiatric Patients: A Reevaluation of Cerebrospinal Fluid Studies
Post, R., & Goodwin, F. (1978) · Springer eBooks · doi:10.1007/978-1-4684-3189-6_3 · Cited by 49
Tan, S. K. H., Hartung, H., Visser-Vandewalle, V. E. R. M., Steinbusch, H. W. M., Temel, Y., & Sharp, T. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.08.027 · Cited by 56
“For example, earlier clinical studies showed decreased 5-hydroxyindoleacetic acid (5-HIAA) levels, the major 5-HT metabolite, in cerebrospinal fluid of depressed patients (Asberg et al., 1976; van Praag and deHaan, 1979), andmore recent neuroimaging studies found changes in levels of cortical and subcortical 5HT recep…”
ResultO’Rourke, H., & Fudge, J. L. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.020 · Cited by 53
“…low levels of 5HT metabolites in response to probenecid in depressed individuals (Van Praag 1977), decreased central 5-HT in the brains of suicide victims (Pare et al 1969), and reports of antidepressant effects of tryptophan, a serotonin precursor (Agurell 1983; Asberg et al 1976; Berger 1975).”
BackgroundEffects of chronic antidepressant treatment on serotonin receptor activity in mice.
Friedman, E., Cooper, T. B., & Dallob, A. (1983) · European Journal of Pharmacology · doi:10.1016/0014-2999(83)90609-x · Cited by 53
Murack, M., Chandrasegaram, R., Smith, K. B., Ah-Yen, E. G., Rheaume, É., Malette-Guyon, É., Nanji, Z., Semchishen, S. N., Latus, O., Messier, C., et al. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.113001 · Cited by 52
Grimes, J. M., & Melloni, R. H. (2006) · Behavioral Neuroscience · doi:10.1037/0735-7044.120.6.1242 · Cited by 50
Prolactin secretion in women with unipolar and bipolar depression
Linkowski, P., Brauman, H., & Mendlewicz, J. (1980) · Psychiatry Research · doi:10.1016/0165-1781(80)90056-6 · Cited by 50
Fluoxetine: Adverse Effects and Drug-Drug Interactions
Messiha, F. S. (1993) · Journal of Toxicology Clinical Toxicology · doi:10.3109/15563659309025765 · Cited by 49
Schneider, L. S. S., Severson, J. A., Chui, H. C., Pollock, V. E., Sloane, R. B., & Fredrickson, E. R. (1988) · Psychiatry Research · doi:10.1016/0165-1781(88)90101-1 · Cited by 49
A double-blind comparison of fluvoxamine, imipramine and placebo in depressed patients
Norton, K., Sireling, L., Bhat, A., Rao, B., & Paykel, E. S. (1984) · Journal of Affective Disorders · doi:10.1016/0165-0327(84)90051-x · Cited by 51
Imbalance of Brain Monoamines and Clinical Disorders
Hornykiewicz, O. (1982) · Progress in brain research · doi:10.1016/s0079-6123(08)64212-0 · Cited by 57
Petruccelli, B. P., Bakris, G. L., Miller, T., Korpi, E. R., & Linnoila, M. (1982) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1982.tb01047.x · Cited by 49
Du, L., Bakish, D., & Hrdina, P. D. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00274-3 · Cited by 48
Berendsen, H. H. G., & Broekkamp, C. L. E. (1991) · Psychopharmacology · doi:10.1007/bf02244313 · Cited by 48
Serotonergic Function and Suicidal Behavior in Personality Disordersa
TRÄSKMAN‐BENDZ, L., ÅSBERG, M., & SCHALLING, D. (1986) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1986.tb27896.x · Cited by 49
Self-citationSwann, A. C., Secunda, S. K., Stokes, P. E., Croughan, J., Davis, J. M., Koslow, S. H., & Maas, J. W. (1990) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1990.tb05469.x · Cited by 48
Orum, M. H., Kara, M. Z., & Egilmez, O. B. (2018) · Journal of Immunoassay and Immunochemistry · doi:10.1080/15321819.2018.1529682 · Cited by 46
FLORES, J., NEVADO, J., PENALVO, G., & Mora-Díez, N. M. (2004) · Talanta · doi:10.1016/j.talanta.2004.05.058 · Cited by 46
Effects of atmospheric electricity on some substrates of disordered social behavior.
Charry, J. M., & Hawkinshire, F. B. (1981) · Journal of Personality and Social Psychology · doi:10.1037//0022-3514.41.1.185 · Cited by 46
Suicidal behavior and growth hormone response to apomorphine test
Pitchot, W., Hansenne, M., Moreno, A. G., & Ansseau, M. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90340-6 · Cited by 46
L-Tryptophan: A Rational Anti-Depressant and a Natural Hypnotic?
Boman, B. (1988) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048678809158946 · Cited by 49
Higher CSF Levels of HVA and 5-HIAA in Delusional Compared to Nondelusional Depression
Åberg-Wistedt, A. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790320097015 · Cited by 46
van der Veen, F. M., Evers, E. A. T., van Deursen, J. A., Deutz, N. E. P., Backes, W. H., & Schmitt, J. A. J. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.01.014 · Cited by 45
Acute changes in 5-HT metabolism after administration
Losada, M. E. O., & Rubio‐Terres, C. (1989) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(89)90186-9 · Cited by 45
Problems With the Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents
Newman, T. B., Garber, A. M., Holtzman, N. A., & Hulley, S. B. (1995) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1995.02170150021003 · Cited by 45
Beck, O., Palmskog, G., & Hultman, E. (1977) · Clinica Chimica Acta · doi:10.1016/0009-8981(77)90472-7 · Cited by 44
Affective Disorders and Aggression Disorders: Evidence for a Common Biological Mechanism
van Praag, H. M. (1986) · Suicide and Life-Threatening Behavior · doi:10.1111/j.1943-278x.1986.tb00348.x · Cited by 49
Åsberg, M., Bertilsson, L., Rydin, E., Schalling, D., Thorén, P., & Träskman‐Bendz, L. (1981) · Elsevier eBooks · doi:10.1016/b978-0-08-026382-3.50038-4 · Cited by 44
Self-citationA double-blind comparison of fluvoxamine, desipramine and placebo in outpatients with depression
Roth, D. A., Mattes, J. A., Sheehan, K. H., & Sheehan, D. V. (1990) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(90)90078-u · Cited by 43
5-HIAA and HVA in CSF in patients with idiopathic pain disorders.
Almay, B., Haggendal, J., von Knorring, L., & Oreland, L. (1987) · Biological Psychiatry · doi:10.1016/0006-3223(87)90162-4 · Cited by 44
The Antidepressant Effects of 5-HT Uptake Inhibitors
Åberg-Wistedt, A. (1989) · British Journal of Psychiatry · doi:10.1192/s0007125000291745 · Cited by 42
Curran, H. V., & LADER, M. H. (1986) · European Journal of Clinical Pharmacology · doi:10.1007/bf00635900 · Cited by 42
Future prospects in depression research
Holtzheimer III, P. E., & Nemeroff, C. B. (2006) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2006.8.2/pholtzheimer · Cited by 40
Integrating the monoamine and cytokine hypotheses of depression: Is histamine the missing link?
Hersey, M., Hashemi, P., & Reagan, L. P. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15392 · Cited by 46
Human alcohol dehydrogenases and serotonin metabolism
Consalvi, V., Mårdh, G., & Vallée, B. L. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(86)80278-9 · Cited by 41
A Comparative Trial of a New Antidepressant, Fluoxetine
Levine, S., Deo, R., & Mahadevan, K. (1987) · British Journal of Psychiatry · doi:10.1192/bjp.150.5.653 · Cited by 41
Migraine headaches and depression
Garvey, M. J., Tollefson, G. D., & Schaffer, C. B. (1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.8.986 · Cited by 40
Upadhyaya, A. K., Pennell, I., Cowen, P. J., & Deakin, J. F. W. (1991) · Journal of Affective Disorders · doi:10.1016/0165-0327(91)90042-q · Cited by 40
Controlled cross‐over study of a 5‐HT uptake inhibiting and an NA uptake inhibiting antidepressant
Åberg, A. (1981) · Acta Psychiatrica Scandinavica Supplementum · doi:10.1111/j.1600-0447.1981.tb00726.x · Cited by 38
Møller, S. E. (1985) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1985.tb10514.x · Cited by 40
The antidepressant efficacy of zimelidine and maprotiline
Montgomery, S., Rani, S. J., McAuley, R., Roy, D. H., & Montgomery, D. (1981) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1981.tb00723.x · Cited by 39
The biochemistry of depression
Lingjærde, O. C. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb00357.x · Cited by 39
Hatanaka, K.-I., Nomura, T., Hidaka, K., Takeuchi, H., Yatsugi, S., Fujii, M., & Yamaguchi, T. (1996) · Neuropharmacology · doi:10.1016/s0028-3908(96)00079-2 · Cited by 38
Rosel, P., Arranz, B., Vallejo, J., Álvarez, P., Menchón, J. M., Palencia, T., & Navarro, M. A. (1999) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00030-5 · Cited by 38
Dikšić, M., Nagahiro, S., & Grdiša, M. (1995) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1995.101 · Cited by 38
Serotonin in Depressive Illness – Studies of CSF 5-HIAA
Åsberg, M., & Bertilsson, L. (1979) · Elsevier eBooks · doi:10.1016/b978-0-08-023089-4.50018-1 · Cited by 38
Self-citationThal, L. J., Sharpless, N. S., WOLFSON, L. I., & Katzman, R. (1980) · Annals of Neurology · doi:10.1002/ana.410070611 · Cited by 37
Human psychobiology in Scandinavia: II. Psychoneuroendocrinology—human stress and coping processes
Lundberg, U. (1984) · Scandinavian Journal of Psychology · doi:10.1111/j.1467-9450.1984.tb01014.x · Cited by 44
Neurobiological Factors in Aggressive Behavior
Garza-Treviño, E. S. (1994) · Psychiatric Services · doi:10.1176/ps.45.7.690 · Cited by 43
MAURIZI, C. P. (1990) · Medical Hypotheses · doi:10.1016/0306-9877(90)90097-x · Cited by 39
Tryptophan hydroxylase gene 218A/C polymorphism is not associated with depressed suicide
Du, L., Faludi, G., Palkovits, M., Bakish, D., & Hrdina, P. D. (2000) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145700001954 · Cited by 36
BIOLOGIC ALTERATIONS IN THE BRAINSTEM OF SUICIDES
Arango, V., Underwood, M. D., & Mann, J. J. (1997) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70331-2 · Cited by 36
Westenberg, H. G. M., & Verhoeven, W. M. A. (1988) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1988.tb06382.x · Cited by 37
Dexamethasone suppression tests in patients with obsessive-compulsive disorder
Lieberman, J. A., Kane, J. M., Sarantakos, S., Cole, K., Howard, A., Borenstein, M., NOVACENKO, H., & Puig-Antich, J. (1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.6.747 · Cited by 36
Relationship of Headaches to Depression
Garvey, M. J., Schaffer, C. B., & Tuason, V. B. (1983) · The British Journal of Psychiatry · doi:10.1192/bjp.143.6.544 · Cited by 36
Lingj�rde, O. (1979) · Psychopharmacology · doi:10.1007/bf00432266 · Cited by 35
Wijk, M. V., Meisch, J.-J., & Korf, J. (1977) · Psychopharmacology · doi:10.1007/bf00497851 · Cited by 35
Videtič, A., Zupanc, T., Pregelj, P., Balažič, J., Tomori, M. Ž., & Komel, R. (2009) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-008-0861-4 · Cited by 34
“[5] who reported low 5hydroxyindolacetic acid (5-HIAA) concentrations in the cerebrospinal fluid of suicide victims [6].”
BackgroundRicaurte, G. A., & McCann, U. D. (2001) · Neurotoxicity Research · doi:10.1007/bf03033232 · Cited by 36
“, 1980) presence of diagnosis of an affective disorder (Mendels et al., 1972; Asberg et al., 1976; Bowers, 1974; Koslow et al., 1983; Meltzer and Lowy, 1987) concurrent use of psychoactive drugs (Eccleston et al.”
BackgroundDursun, S. M., Szemis, A., Andrews, H., Whitaker, P., & Reveley, M. A. (2000) · PubMed Central · Cited by 34
Age-related changes in serotonin 5HT2 receptors on human blood platelets
Biegon, A. R., & Greuner, N. (1992) · Psychopharmacology · doi:10.1007/bf02245309 · Cited by 34
The classification of affective disorders: a synthesis of old and new concepts.
Roth, R., & Barnes, T. (1981) · Comprehensive Psychiatry · doi:10.1016/0010-440x(81)90053-5 · Cited by 30
Stahl, S. M., & Palazidou, L. (1986) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(86)90384-6 · Cited by 40
Research on the Biologic Aspects of Violence
Burrowes, K., Hales, R. E., & Arrington, E. D. (1988) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30465-9 · Cited by 36
Shamsipur, M., Dastjerdi, L. S., Haghgoo, S., Armspach, D., Matt, D., & Aboul-Enein, H. Y. (2007) · Analytica Chimica Acta · doi:10.1016/j.aca.2007.08.017 · Cited by 33
Voget, M., Rummel, J., Avchalumov, Y., Sohr, R., Haumesser, J. K., Rea, E., Mathé, A. A., Hadar, R., van Riesen, C., & Winter, C. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.05.027 · Cited by 36
Oral contraceptives and depressive symptomatology: Biologic mechanisms
Parry, B. L., & Rush, A. J. (1979) · Comprehensive Psychiatry · doi:10.1016/0010-440x(79)90006-3 · Cited by 33
The limbic system and aggression in humans
Eichelman, B. S. (1983) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(83)90044-1 · Cited by 33
Relationships between CSF levels of endorphins and monoamine metabolites in chronic pain patients
Almay, B. G. L., Johansson, F., von Knorring, L., Sedvall, G., & Terenius, L. Y. (1980) · Psychopharmacology · doi:10.1007/bf00431968 · Cited by 33
Molecular tools for assessing human depression by positron emission tomography
Smith, D. F., & Jakobsen, S. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.04.005 · Cited by 32
“Current notions on molecular mechanism in depression have, however, advanced far beyond postulates of the classical monoamine hypotheses (Schildkraut and Kety, 1967; Asberg et al., 1976; Meltzer and Lowy, 1987).”
Suicide Research: Overview and Introduction
STOFF, D. M., & MANN, J. J. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb52352.x · Cited by 28
An exploratory approach to the serotonergic hypothesis of depression: bridging the synaptic gap
Dursun, S. M., Blackburn, J., & Kutcher, S. (2001) · Medical Hypotheses · doi:10.1054/mehy.2000.1187 · Cited by 32
Noradrenaline, depressive illness, and the action of amitriptyline
Ghose, K., & Coppen, A. (1977) · Psychopharmacology · doi:10.1007/bf00426542 · Cited by 10
Alpha lipoic acid: a novel treatment for depression
Salazar, M. R. (2000) · Medical Hypotheses · doi:10.1054/mehy.2000.1103 · Cited by 31
The psychological autopsy: a useful tool for determining proximate causation in suicide cases.
Jacobs, D. H., & Klein-Benheim, M. (1995) · PubMed · Cited by 31
Effects of repeated doses of fluvoxamine, mianserin and placebo on memory and measures of sedation
Curran, H. V., Shine, P. J., & LADER, M. H. (1986) · Psychopharmacology · doi:10.1007/bf00174375 · Cited by 31
“In the search for more effective antidepressants with fewer unwanted effects, attention has been focussed on the development of selective 5-HT uptake inhibitors (Asberg et al. 1976).”
Backgroundvan Donkelaar, E. L., Blokland, A., Lieben, C. K., Kenis, G., Ferrington, L., Kelly, P. A. T., Steinbusch, H. W. M., & Prickaerts, J. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.08.010 · Cited by 34
“…is a heterogeneous disorder with complex molecular pathophysiological mechanisms, a dysfunctional serotonergic neurotransmitter system is widely accepted to be one of the main factors underlying the development of depressive symptomatology (Asberg et al., 1976a; Meltzer, 1990; Leonard, 2007).”
BackgroundInfluentialThe Benefits and Risks of 5-HT Uptake Inhibitors in Depression: Chairman's Introduction
Montgomery, S. (1988) · The British Journal of Psychiatry · doi:10.1192/s0007125000297237 · Cited by 31
Expression of Serotonin Transporter mRNA in Human Brainstem Raphe Nuclei
McLaughlin, D. P. (1996) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00093-0 · Cited by 29
A double‐blind comparison of zimelidine and desipramine in endogenous depression
Lingjærde, O. C., Bratfos, O., Bratlid, T., & Haug, J. O. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb06977.x · Cited by 29
Niesink, R., & van Ree, J. M. (1982) · Neuropharmacology · doi:10.1016/0028-3908(82)90144-7 · Cited by 9
Benefits and risks of hormone replacement therapy (HRT)
Breckwoldt, M., Keck, C., & Karck, U. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00047-4 · Cited by 28
The organic contribution to depressive illness in patients with epilepsy
Robertson, M. M. (1989) · Journal of Epilepsy · doi:10.1016/0896-6974(89)90002-9 · Cited by 28
Winslow, J., DeBold, J. F., & Miczek, K. A. (1987) · Topics in the neurosciences · doi:10.1007/978-94-009-3359-0_14 · Cited by 29
Recent pharmacologic advances in antidepressant therapy
Kilts, C. D. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90358-1 · Cited by 31
Differential effects on suicidal ideation of mianserin, maprotiline and amitriptyline.
Montgomery, S., Cronholm, B., Asberg, M., & Montgomery, D. (1978) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1978.tb04580.x · Cited by 28
Robillard, R., Saad, M., Ray, L. B., Bujaki, B., Douglass, A. B., Lee, E. K., Soucy, L., Spitale, N., Koninck, J. D., & Kendzerska, T. (2020) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.8942 · Cited by 29
“For instance, individuals with depression have low levels of plasma tryptophan (a 5-HT precursor) 7,8 and 5-HT metabolites in the cerebrospinal fl uid, low 5-HT1A receptor binding, 9 – 11 and low availability of 5-HT reuptake sites in the brainstem.”
Wong, P., Sze, Y., Gray, L. J. M., Chang, C. C. R., Cai, S., & Zhang, X. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00094 · Cited by 34
Serotonergic function and late luteal phase dysphoric disorder
Veeninga, A. T., & Westenberg, H. G. M. (1992) · Psychopharmacology · doi:10.1007/bf02245301 · Cited by 27
Fatty acid and tryptophan changes on disturbing groups of rats and caging them singly
Knott, P. J., Hutson, P. H., & Curzon, G. (1977) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(77)90141-1 · Cited by 27
von Knorring, L., Perris, C., Oreland, L., Eisemann, M., Eriksson, U., & Perris, H. (2005) · Journal of neural transmission · doi:10.1007/bf01254760 · Cited by 12
“Patients with low concentrations of 5-HIAA in the CSF have earlier been found to have an increased tendency to suicidal behaviour (~4sberg et al., 1976 a, 1976 b; Trdskman-Bendz, 1980).”
InfluentialBrain noradrenaline, depression and antidepressant drugs: facts and hypothesis
Kostowski, W. (1981) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(81)90351-5 · Cited by 27
Differentiation of Primary Emotions through Neuromodulators: Review of Literature
Gu, S., Wang, F., Yuan, T., Benyu, G., & Huang, J. H. (2015) · International Journal of Neurology Research · doi:10.17554/j.issn.2313-5611.2015.01.19 · Cited by 30
Zalsman, G., Huang, Y., Oquendo, M. A., Brent, D. A., Giner, L., Haghighi, F. G., Burke, A. K., Ellis, S. P., Currier, D., & Mann, J. J. (2008) · Archives of Suicide Research · doi:10.1080/13811110802324912 · Cited by 29
Hatanaka, K.-I., Yatsugi, S., & Yamaguchi, T. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00173-4 · Cited by 28
Metadata
- Authors
- Åsberg, M., Thorén, P., Traskman, L., Bertilsson, L., & Ringberger, V.
- Affiliations
- Karolinska Institutet (SE)
- Karolinska Institute, Department of Psychiatry, Karolinska Hospital, S-J04 OJ Stockholm 60, Sweden
- Karolinska Institute, Department of Clinical Pharmacology, Huddinge Hospital, S-J41 86 Huddinge, Sweden
- Venue
- Science
- Published
- 1976-02-06
- Volume
- 191
- Issue
- 4226
- Pages
- 478-480
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2030998472
- Cited by
- 682
- References
- 20
- Citations by year
- 2026: 1 · 2025: 8 · 2024: 6 · 2023: 3 · 2022: 2 · 2021: 8 · 2020: 9 · 2019: 7 · 2018: 8 · 2017: 6 · 2016: 5 · 2015: 10 · 2014: 9 · 2013: 5 · 2012: 6
- FWCI
- 25.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- 5-hydroxyindoleacetic acid, cerebrospinal fluid, depression, serotonin turnover, depression severity, mood disorders
- MeSH terms
- Antidepressive Agents, Depression, Female, Humans, Hydroxyindoleacetic Acid, Male, Serotonin, Sex Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.